Weight loss and dietary changes to prevent Alzheimer's in adults with Down syndrome
Official title: The Impact of Weight Loss on Alzheimer's Disease Risk in Adults With Down Syndrome
Run by University of Kansas Medical Center · NCT05985486 · Data updated 2026-11-12
This study is testing if losing weight or changing diets can help prevent or delay Alzheimer's in adults with Down syndrome.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 64 Years |
| Sex | All |
| Enrollment | 81 (estimated) |
| Sponsor | University of Kansas Medical Center Academic / other |
| Locations | 1 site (Kansas City, Kansas) |
| Status | Recruiting |
| Started | October 22, 2024 |
| Main results expected | September 30, 2027 |
| Study ends | September 30, 2027 |
| Registry record updated | March 11, 2026 |
| Trial ID | NCT05985486 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with Down syndrome who have a BMI between 25 and 50 and can communicate verbally.
✕Probably not a fit
Patients with a diagnosis of dementia or serious medical conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate whether weight loss or dietary changes can help prevent or delay the onset of Alzheimer's Disease in adults with Down syndrome. Participants will be randomly assigned to either a weight loss group, which will follow a reduced energy diet and attend monthly remote education sessions, or a control group receiving general health education. Over the course of 12 months, all participants will visit the University of Kansas Medical Center three times for assessments including blood draws, cognitive testing, MRI scans, and evaluations of diet and body weight.
Why it matters
Potential benefit: If successful, this study could provide a new approach to delaying Alzheimer's Disease in adults with Down syndrome through lifestyle modifications.
How similar studies have gone: While there have been studies on lifestyle changes in other populations, this specific approach in adults with Down syndrome is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of Down syndrome * BMI of 25 to 50 kg/m2 * Ability to communicate through spoken language. * Ability to come to the University of Kansas Medical Center 3 times across 1 year for outcomes testing * Living at home with a parent/guardian, or in a supported living environment with a caregiver who assists with food shopping, meal planning, and meal preparation and agrees to serve as a study partner including providing transportation to our facilities for study assessments. Exclusion Criteria: * Diagnosis of dementia * Insulin dependent diabetes * Participation in a weight management program involving diet or physical activity in the past 6 mos. * Dairy allergy * Serious medical risk (e.g., cancer, recent heart attack, stroke, pregnancy, angioplasty) * Unwilling to be randomized * Contraindications for MRI, including metal implants or devices incompatible with MRI such as pacemakers, claustrophobia, and inability to lay in a supine position * Use of GLP-1 medications * Use of anti-amyloid medications
Where it's running
-
University of Kansas Medical Center
Kansas City, Kansas, United States Recruiting
Study contacts
- Study coordinator: Lauren Ptomey, PhD
- Email: lptomey@kumc.edu
- Phone: 913-588-7982
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Levetiracetam to prevent seizures in adults with Down syndrome and Alzheimer's disease
This trial will test whether the anti-seizure medicine levetiracetam can prevent tonic-clonic seizures and slow cognitive decline in adults over 40 who have Down syndrome and symptomatic Alzheimer's disease.
-
Cholinergic Integrity in Down Syndrome and Aging
This study tests a brain imaging tracer to see if cholinergic nerve health declines with age in adults with Down syndrome who may be at risk for Alzheimer's disease.
-
Investigating the link between obesity and Alzheimer's disease
This study is trying to see how being overweight or obese affects the risk of developing Alzheimer's disease in healthy adults aged 40-60.
-
Observational cohort for adults with Down syndrome and Alzheimer's disease
This study is trying to understand how thinking skills relate to Alzheimer's disease signs in adults with Down syndrome to help plan future treatments.
-
Ocular Changes in People Using Tirzepatide or Semaglutide
This study checks whether eye structure and blood vessels change in adults with obesity who are taking semaglutide or tirzepatide as part of routine care.
-
Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes
This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.